The Comprehensive Systematic Review of Probiotic Interventions and The Gut Lung Axis in Critically ill Patients with Lung Edema
Keywords:
Probiotics, synbiotics, gut-lung axis, critical illness, ventilator-associated pneumonia, ARDS, intensive care unitAbstract
Introduction: Critically ill patients with lung edema experience significant morbidity and mortality, with the gut-lung axis emerging as a potential therapeutic target. Probiotic interventions may modulate this bidirectional relationship, but evidence remains conflicting. This systematic review synthesizes evidence on probiotic effects on the gut-lung axis in critically ill adults with lung edema.
Methods: A systematic review was conducted following PRISMA guidelines. We screened 200 sources from databases including PubMed, Scopus, and Web of Science (2000-2026). Included studies were randomized controlled trials, cohort studies, and meta-analyses examining probiotic or synbiotic interventions in critically ill adults (≥18 years) with lung edema/ARDS. Primary outcomes included ventilator-associated pneumonia (VAP), mechanical ventilation duration, and gut-lung axis mechanisms. Quality assessment used Cochrane Risk of Bias tools.
Results: Forty-eight primary studies and 52 meta-analyses/systematic reviews were included (total N >15,000 patients). Probiotics reduced VAP incidence (RR 0.52-0.75), with synbiotics showing greater efficacy (RR 0.61, 95% CI 0.47-0.80). Mechanical ventilation duration decreased by 1-2.5 days, and ICU length of stay by 1-2 days. Mortality reduction was inconsistent, though severe sepsis subgroups showed benefit (OR 0.38, 95% CI 0.16-0.93). Mechanistically, probiotics improved gut barrier function (reduced lactulose-mannitol ratio, enhanced tight junction proteins), modulated systemic inflammation (IL-6 reduction 140 pg/mL, CRP reduction 72.7%), increased short-chain fatty acid production, and reduced pathogenic colonization. The largest trial (PROSPECT, n=2,653) found no VAP reduction, highlighting context-dependent efficacy. Safety concerns included probiotic bacteremia (1.1% vs 0.1% in PROSPECT).
Discussion: Probiotic efficacy is population-specific, with consistent benefits in trauma, surgical, and COVID-19 patients, but minimal effects in general mixed ICU populations receiving contemporary care. Synbiotics, higher doses (≥5×10⁹ CFU/day), and longer duration (≥14 days) optimize outcomes. Methodological quality explains discrepancies between early positive meta-analyses and recent negative trials.
Conclusion: Probiotics modulate the gut-lung axis through multiple mechanisms, reducing VAP and ICU stay in selected populations. Routine use in unselected ICU patients is not supported, but targeted therapy in trauma and specific subgroups may be beneficial. Further research should optimize strain selection, dosing, and identify responsive phenotypes.
References
E. Petrof, R. Dhaliwal, W. Manzanares, et al (2012) Probiotics in the critically ill: A systematic review of the randomized trial evidence. Critical Care Medicine. https://doi.org/10.1097/CCM.0b013e318260cc33
Hongzhuan Song, Wenqing Hu, Xiujie Zhou, et al (2022) Clinical Benefits From Administering Probiotics to Mechanical Ventilated Patients in Intensive Care Unit: A PRISMA-Guided Meta-Analysis. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2021.798827
Bo Wang, Ji Xie, Yao Teng (2023) A meta-analysis of the effects of probiotics on various parameters in critically ill ventilated individuals. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/157407
Sameer Sharif, Alisha Greer, Clarissa Skorupski, et al (2022) Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Critical Care Medicine. https://doi.org/10.1097/CCM.0000000000005580
J. Johnstone, M. Meade, F. Lauzier, et al (2021) Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial. Journal of the American Medical Association (JAMA). https://doi.org/10.1001/jama.2021.13355
I. Siempos, T. Ntaidou, M. Falagas (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials*. Critical Care Medicine. https://doi.org/10.1097/CCM.0b013e3181c8fe4b
W. Manzanares, M. Lemieux, P. Langlois, P. Wischmeyer (2016) Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Critical Care. https://doi.org/10.1186/s13054-016-1434-y
D. Barraud, P. Bollaert, S. Gibot (2013) Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest. https://doi.org/10.1378/chest.12-1745
A. Mahmoodpoor, Roya Ghaemi, Kamran Shadvar, et al (2022) Effect of a probiotic preparation on gut microbiota in critically ill septic patients admitted to intensive care unit: A pilot randomized controlled trial. Pharmaceutical Sciences. https://doi.org/10.34172/ps.2022.20
Kanukuntla Saikrishna, Daizee Talukdar, Santanu Das, et al (2023) Study on Effects of Probiotics on Gut Microbiome and Clinical Course in Patients with Critical Care Illnesses. Microbial Ecology. https://doi.org/10.1007/s00248-023-02224-8
Kentarou Shimizu, Tomoki Yamada, H. Ogura, et al (2018) Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial. Critical Care. https://doi.org/10.1186/s13054-018-2167-x
Alenka Spindler-Vesel, S. Bengmark, I. Vovk, et al (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN - Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1177/0148607107031002119
Yuxin Leng, Chao Jiang, Xiaofang Xing, et al (2020) Prevention of Severe Intestinal Barrier Dysfunction Through a Single-Species Probiotics Is Associated With the Activation of Microbiome-Mediated Glutamate-Glutamine Biosynthesis. Shock. https://doi.org/10.1097/SHK.0000000000001593
S. Sanaie, M. Ebrahimi-Mameghani, H. Hamishehkar, et al (2014) Effect of a multispecies probiotic on inflammatory markers in critically ill patients: A randomized, double-blind, placebo-controlled trial. Journal of Research in Medical Sciences
A. Saviano, A. Potenza, V. Siciliano, et al (2022) COVID-19 Pneumonia and Gut Inflammation: The Role of a Mix of Three Probiotic Strains in Reducing Inflammatory Markers and Need for Oxygen Support. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11133758
M. T. Pham, A. Yang, Ming-Shan Kao, et al (2021) Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein. Journal of Nutritional Biochemistry. https://doi.org/10.1016/j.jnutbio.2021.108821
Kai Wang, Qing Zeng, Kexun Li, et al (2022) Efficacy of probiotics or synbiotics for critically ill adult patients: a systematic review and meta-analysis of randomized controlled trials. Burns & Trauma. https://doi.org/10.1093/burnst/tkac004
Orsalia Konsta, V. Linardatou, Yiannis Papachatzakis, et al (2025) The effects of probiotics, prebiotics and synbiotics on infections and clinical outcomes in critical illness: A systematic review. Health & Research Journal. https://doi.org/10.12681/healthresj.40091
Wan-Jie Gu, Teng Deng, Y. Gong, et al (2013) The effects of probiotics in early enteral nutrition on the outcomes of trauma: a meta-analysis of randomized controlled trials. JPEN - Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1177/0148607112463245
L. Morrow, M. Kollef, T. Casale (2010) Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200912-1853OC
J. Zeng, Chun-ting Wang, Fu-Shen Zhang, et al (2016) Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Medicine. https://doi.org/10.1007/s00134-016-4303-x
V. Trinchieri, M. Marazzato, G. Ceccarelli, et al (2022) Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients. Biomedicines. https://doi.org/10.3390/biomedicines10081851
Qiang Li, F. Cheng, Qiling Xu, et al (2021) The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2021.107531
P. Lu, Dongliang Li, Qing Tian, et al (2024) Effect of mixed probiotics on pulmonary flora in patients with mechanical ventilation: an exploratory randomized intervention study. European Journal of Medical Research. https://doi.org/10.1186/s40001-024-02059-0
Yonglin Zhu, Guannan Ma, Wei Ren, et al (2023) Effect of oral probiotics on clinical efficacy and intestinal flora in elderly severe pneumonia patients. Medicine. https://doi.org/10.1097/MD.0000000000036320
Ioannis Mitrou, George Dimopoulos, Konstantina Dakou, et al (2025) Interactions of Probiotics with the Immune Cells of Patients with COVID-19 Pneumonia. Journal of Innate Immunity. https://doi.org/10.1159/000545873
A. Naseri, Sepideh Seyedi-Sahebari, A. Mahmoodpoor, S. Sanaie (2022) Probiotics in Critically Ill Patients: An Umbrella Review. Indian Journal of Critical Care Medicine. https://doi.org/10.5005/jp-journals-10071-24129
Paniz Anvarifard, Maryam Anbari, F. Ghalichi, et al (2024) The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis. Food & Function. https://doi.org/10.1039/d3fo04653b
Jie Wang, Hui Ke, Kai-Xiong Liu, J. Qu (2020) Effects of exogenous probiotics on the gut microbiota and clinical outcomes in critically ill patients: a randomized controlled trial. Annals of Palliative Medicine. https://doi.org/10.21037/apm-20-202
D. Cook, J. Johnstone, J. Marshall, et al (2016) Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial. Trials. https://doi.org/10.1186/s13063-016-1495-x
Abdulaziz Alsuwaylihi, F. McCullough (2022) The safety and efficacy of probiotic supplementation for critically ill adult patients: a systematic review and meta-analysis. Nutrition reviews. https://doi.org/10.1093/nutrit/nuac059
Sato Takeaki (2025) Probiotic treatment in an intensive care unit: a narrative review. Journal of Intensive Care. https://doi.org/10.1186/s40560-025-00803-0
Z. Lee, Charles Chin Han Lew, Alfonso Ortiz-Reyes, et al (2023) Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2023.01.019
Alexandra Menni, G. Tzikos, Barbara Fyntanidou, et al (2024) The Effect of Probiotics on the Prognostication of the Neutrophil-to-Lymphocyte Ratio in Severe Multi-Trauma Patients. Journal of Personalized Medicine. https://doi.org/10.3390/jpm14040419
Kentarou Shimizu, H. Ogura (2022) Comment on: “Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial”. Clinical Nutrition Open Science. https://doi.org/10.1016/j.nutos.2022.07.003
Wen Sun, Pingping Wang, Jingwen Xu, et al (2025) The effects of oral probiotics quadruple live bacteria tablets on the serum non-targeted metabolomics of mechanically ventilated patients. Egyptian Journal of Bronchology. https://doi.org/10.1186/s43168-025-00480-5
N. Crooks (2019) An open-label study into the efficacy and dosing of probiotic Escherichia coli Nissle 1917 for the prevention of Gram-negative gastric colonisation in ventilated intensive care patients
L. Morrow, P. Wischmeyer (2017) Blurred Lines: Dysbiosis and Probiotics in the ICU. Chest. https://doi.org/10.1016/j.chest.2016.10.006
C. Mcnaught, N. Woodcock, A. D. Anderson, J. Macfie (2005) A prospective randomised trial of probiotics in critically ill patients. Clinical Nutrition. https://doi.org/10.1016/J.CLNU.2004.08.008
L. Morrow, V. Gogineni, M. Malesker (2012) Probiotic, prebiotic, and synbiotic use in critically ill patients. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0b013e3283514b17
Kalliopi D. Synodinou, Maroulla D Nikolaki, K. Triantafyllou, A. Kasti (2022) Immunomodulatory Effects of Probiotics on COVID-19 Infection by Targeting the Gut–Lung Axis Microbial Cross-Talk. Microorganisms. https://doi.org/10.3390/microorganisms10091764
C. A. Jacobi, C. Schulz, P. Malfertheiner (2011) Treating critically ill patients with probiotics: Beneficial or dangerous? Gut Pathogens. https://doi.org/10.1186/1757-4749-3-2
A. Mahmoodpoor, H. Hamishehkar, Roghaieh Asghari, et al (2018) Effect of a Probiotic Preparation on Ventilator‐Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double‐Blind Randomized Controlled Trial. Nutrition in clinical practice. https://doi.org/10.1002/ncp.10191
P. Batra, K. Soni, P. Mathur (2020) Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials. Journal of Intensive Care. https://doi.org/10.1186/s40560-020-00487-8
C. Forestier, D. Guélon, Valérie Cluytens, et al (2008) Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Critical Care. https://doi.org/10.1186/cc6907
M. Ebrahimi-Mameghani, S. Sanaie, A. Mahmoodpoor, H. Hamishehkar (2013) Effect of a probiotic preparation (VSL#3) in critically ill patients: A randomized, double-blind, placebo-controlled trial (Pilot Study). Pakistan Journal of Medical Sciences. https://doi.org/10.12669/PJMS.292.3370
Ying Xu, Rui-Xiang Chen, Jun Jin (2020) Effect of probiotics on prevention of ventilator-associated pneumonia and intestinal function in critically ill patients. https://doi.org/10.3760/CMA.J.CN131368-20190906-01252
V. Stadlbauer, A. Horvath, I. Komarova, et al (2019) Dysbiosis in early sepsis can be modulated by a multispecies probiotic: a randomised controlled pilot trial. Beneficial Microbes. https://doi.org/10.3920/BM2018.0067
Ausama A. Malik, R. Rajandram, P. Tah, et al (2016) Microbial cell preparation in enteral feeding in critically ill patients: A randomized, double-blind, placebo-controlled clinical trial. Journal of critical care. https://doi.org/10.1016/j.jcrc.2015.12.008
S. Abbasi, Amirhossein Akhavan Sigari, S. Rostami, et al (2023) Effect of enteral probiotics on prognostic scores and C-reactive protein levels in critically ill multiple trauma patients: A randomized, double-blind, placebo-controlled clinical trial. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2023.02.025
E. Litton, M. Anstey, David I. Broadhurst, et al (2020) Study protocol for the safety and efficacy of probiotic therapy on days alive and out of hospital in adult ICU patients: the multicentre, randomised, placebo-controlled Restoration Of gut microflora in Critical Illness Trial (ROCIT). BMJ Open. https://doi.org/10.1136/bmjopen-2019-035930
D. Barraud, Claire Blard, F. Hein, et al (2010) Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Medicine. https://doi.org/10.1007/s00134-010-1927-0
Jie Zhao, Lei-qing Li, Cheng-yang Chen, et al (2020) Do probiotics help prevent ventilator-associated pneumonia in critically ill patients? A systematic review with meta-analysis. ERJ Open Research. https://doi.org/10.1183/23120541.00302-2020
L. Morrow, T. Casale, M. Kollef (2009) PROBIOTIC PROPHYLAXIS OF VENTILATOR-ASSOCIATED PNEUMONIA. https://doi.org/10.1378/CHEST.136.4_MEETINGABSTRACTS.36S-H
Yong-fang Tian, Hongmei Ran, Xudong Wen, et al (2023) Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2023.1179432
M. Tsilika, Giannoula Thoma, Z. Aidoni, et al (2021) A FOUR PROBIOTIC PREPARATION FOR VENTILATOR-ASSOCIATED PNEUMONIA IN MULTI-TRAUMA PATIENTS: RESULTS OF A RANDOMIZED CLINICAL TRIAL. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2021.106471
Bengt Klarin, M. Johansson, G. Molin, et al (2005) Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Critical Care. https://doi.org/10.1186/cc3522
Bengt Klarin, A. Adolfsson, A. Torstensson, A. Larsson (2018) Can probiotics be an alternative to chlorhexidine for oral care in the mechanically ventilated patient? A multicentre, prospective, randomised controlled open trial. Critical Care. https://doi.org/10.1186/s13054-018-2209-4
M. Malian, R. Reichenbach, A. Peck, Nikolai Pamukov (2012) 1087: PROBIOTIC SUPPLEMENTATION IN CRITICAL CARE. https://doi.org/10.1097/01.ccm.0000425300.89190.4b
Sarah Prisco, Madelyn L. Blake, F. Kazmirczak, et al (2024) Lactobacillus Restructures the Micro/Mycobiome to Combat Glycoprotein-130 Associated Microtubule Remodeling and Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. bioRxiv. https://doi.org/10.1101/2024.08.19.608469
Takao Arai, S. Mishima, S. Ohta, et al (2018) Bifidobacterium longum BB536 and Changes in Septicemia Markers Associated with Antibiotic Use in Critically Ill Patients. https://doi.org/10.4172/2324-903X.1000161
A. Tursi, A. Papa (2020) Intestinal Microbiome Modulation During Coronavirus Disease 2019: Another Chance to Manage the Disease? Gastroenterology. https://doi.org/10.1053/j.gastro.2020.08.056
A. Tranberg, Bengt Klarin, Julia Johansson, L. Påhlman (2020) Efficacy of Lactiplantibacillus plantarum 299 and 299v against nosocomial oropharyngeal pathogens in vitro and as an oral prophylactic treatment in a randomized, controlled clinical trial. MicrobiologyOpen. https://doi.org/10.1002/mbo3.1151
L. Abenavoli, E. Scarpellini, Maria Rosaria Paravati, et al (2023) Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition. Nutrients. https://doi.org/10.3390/nu15163569
A. Schuurman, R. F. Kullberg, W. Wiersinga (2022) Probiotics in the Intensive Care Unit. Antibiotics. https://doi.org/10.3390/antibiotics11020217
Kentarou Shimizu, Masahiro Ojima, H. Ogura (2021) Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients. Nutrients. https://doi.org/10.3390/nu13072439
K. Kotzampassi, E. Giamarellos‐Bourboulis, A. Voudouris, et al (2006) Benefits of a Synbiotic Formula (Synbiotic 2000Forte®) in Critically Ill Trauma Patients: Early Results of a Randomized Controlled Trial. World Journal of Surgery. https://doi.org/10.1007/s00268-005-0653-1
K. Madsen (2008) Probiotics in Critically Ill Patients. Journal of Clinical Gastroenterology. https://doi.org/10.1097/MCG.0b013e31817283cb
N. Crooks, C. Snaith, D. Webster, et al (2012) Clinical review: Probiotics in critical care. Critical Care. https://doi.org/10.1186/cc11382
Bengt Klarin, G. Molin, B. Jeppsson, A. Larsson (2008) Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Critical Care. https://doi.org/10.1186/cc7109
M. Theodorakopoulou, E. Perros, E. Giamarellos‐Bourboulis, G. Dimopoulos (2013) Controversies in the management of the critically ill: the role of probiotics. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2013.04.010
L. Khailová, C. Baird, Aubri A Rush, et al (2013) Lactobacillus rhamnosus GG Improves Outcome in Experimental Pseudomonas aeruginosa Pneumonia: Potential Role of Regulatory T Cells. Shock. https://doi.org/10.1097/SHK.0000000000000066
J. Kenna, Leana Mahmoud, A. Zullo, et al (2016) Effect of Probiotics on the Incidence of Healthcare-Associated Infections in Mechanically Ventilated Neurocritical Care Patients. Nutrition in clinical practice. https://doi.org/10.1177/0884533615620349
E. Giamarellos‐Bourboulis, S. Bengmark, K. Kanellakopoulou, K. Kotzampassi (2009) Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. Journal of Trauma. https://doi.org/10.1097/TA.0b013e31819d979e
Najmeh Seifi, M. Safarian, M. Nematy, et al (2019) Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies. Trials. https://doi.org/10.1186/s13063-020-4136-3
Anand Prasoon, R. Singh, R. Anand, et al (2022) A Randomized Controlled Trial to Evaluate the Use of Probiotics in Prevention of Ventilator-Associated Pneumonia in Critically Ill ICU Patients. Journal of Cardiac Critical Care TSS. https://doi.org/10.1055/s-0042-1754161
Xintao Huang, Rong Wu, Xiaoqi Liang, et al (2025) Streptococcus salivarius-derived ilexgenin A alleviates pneumonia through the gut-lung axis. mSystems. https://doi.org/10.1128/msystems.00731-25
V. Lau, Feng Xie, R. Fowler, et al (2022) Health economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): a cost-effectiveness analysis. Canadian Journal of Anesthesia/Journal canadien d'anesthésie. https://doi.org/10.1007/s12630-022-02335-9
O. Putra, H. Pebrianton, S. Suharjono, et al (2017) The Role of Probiotics in Inflammatory Responses of Critically-Ill Burn Patients (A Randomized Clinical Trial). https://doi.org/10.2991/HSIC-17.2017.61
Nur Febriany Nasseer, M. S. Noer, S. Rizaliyana (2013) The Effect of Giving Single Strain Probiotics
H. Nugroho (2018) Pengaruh Pemberian Probiotik Terhadap Kadar Procalcitonin dan Lama Perbaikan Klinis Pasien Pneumonia
Kentarou Shimizu, Hiroshi Ogura, Jun Oda (2025) Gut dysbiosis and its treatment in patients with critical illness. Acute Medicine & Surgery. https://doi.org/10.1002/ams2.70068
G. Rijkers (2011) Probiotics for severe trauma patients. Critical Care. https://doi.org/10.1186/cc10589
Gloria M Agudelo-Ochoa, N. A. Giraldo-Giraldo, Carlos J. Barrera-Causil, Beatriz E. Valdés-Duque (2016) Microbiota intestinal y ácidos grasos de cadena corta en pacientes críticos. https://doi.org/10.17533/UDEA.PENH.V18N2A06
Min Tan, Jing-ci Zhu, Jiang Du, et al (2011) Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Critical Care. https://doi.org/10.1186/cc10579
T. J. Frohmader, W. Chaboyer, I. Robertson, J. Gowardman (2010) Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. American Journal of Critical Care. https://doi.org/10.4037/ajcc2010976
Leena Sapra, C. Saini, Sneha Das, et al (2023) Lactobacillus rhamnosus (LR) ameliorates pulmonary and extrapulmonary acute respiratory distress syndrome (ARDS) via targeting neutrophils. Clinical Immunology. https://doi.org/10.1016/j.clim.2023.109872
D. Tok, O. Ilkgul, S. Bengmark, et al (2007) Pretreatment with pro- and synbiotics reduces peritonitis-induced acute lung injury in rats. Journal of Trauma. https://doi.org/10.1097/01.TA.0000236019.00650.00
Leena Sapra, Sneha Das, C. Saini, et al (2023) Lactobacillus rhamnosus (LR) ameliorates acute respiratory distress syndrome (ARDS) via modulating the lung “Innate Lymphoid Cells (ILCs)-Mononuclear Phagocytic System (MPS)”. bioRxiv. https://doi.org/10.1101/2023.08.10.552899
G. Stavrou, K. Kotzampassi (2016) Gut microbiome, surgical complications and probiotics. Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology. https://doi.org/10.20524/aog.2016.0086
Sarah Prisco, Madelyn L. Blake, F. Kazmirczak, et al (2025) Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension. Circulation: Heart Failure. https://doi.org/10.1161/CIRCHEARTFAILURE.124.012524
Marel C E van Ruissen, L. Bos, R. Dickson, et al (2019) Manipulation of the microbiome in critical illness—probiotics as a preventive measure against ventilator-associated pneumonia. Intensive Care Medicine Experimental. https://doi.org/10.1186/s40635-019-0238-1
M. Karen, O. Yuksel, N. Akyürek, et al (2010) Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2009.02.008
B. Weiss, Y. Bujanover, Y. Yahav, et al (2010) Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: A pilot study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.21138
H. Abuohashish, Eman H. Zaghloul, Amany S El Sharkawy, et al (2021) Pharmacological Effects of Marine-Derived Enterococcus faecium EA9 against Acute Lung Injury and Inflammation in Cecal Ligated and Punctured Septic Rats. BioMed Research International. https://doi.org/10.1155/2021/5801700
Yuexia Sun, Chenyu Wang, Hai-li Wang, et al (2021) Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-022-01965-5
C. Alberda, S. Marcushamer, T. Hewer, et al (2018) Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile. Nutrients. https://doi.org/10.3390/nu10050539
Lufang Chen, Hanyu Li, Yue Chen, Yunmei Yang (2020) Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles. Nutrition (Burbank, Los Angeles County, Calif). https://doi.org/10.1016/j.nut.2020.110863
Shao-Huan Lan, Shun-Hsing Hung, Shen-Peng Chang, et al (2022) Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials. Expert Review of Anti-Infective Therapy. https://doi.org/10.1080/14787210.2022.2089652
P. Gutiérrez-Castrellón, Tania Gandara-Martí, Ana T Abreu Y Abreu, et al (2022) Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut microbes. https://doi.org/10.1080/19490976.2021.2018899
Angela Horvath, H. Habisch, Barbara Prietl, et al (2024) Alteration of the Gut–Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study. Nutrients. https://doi.org/10.3390/nu16223840
Jian Shen, Shuting Wang, Yong Huang, et al (2023) Lactobacillus reuteri Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the Gut Microbiota in Mice. Nutrients. https://doi.org/10.3390/nu15194256
Jiali Ni, Jian Shen, Fengjiao Wang, et al (2026) Lactobacillus fermentum remodeled the lung microbiota by crosstalk with the gut and lungs and regulated the PI3K-AKT pathway to alleviate acute lung injury. Food & Function. https://doi.org/10.1039/d5fo04619j
Lulong Bo, Jinbao Li, Tianzhu Tao, et al (2014) Probiotics for preventing ventilator-associated pneumonia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD009066.pub2
Yumin Kim, M. S. Ki, M. H. Shin, et al (2025) Thrombospondin-1 modulation by Bifidobacterium spp. mitigates lung damage in an acute lung injury mouse model. Microbiology Research. https://doi.org/10.1016/j.micres.2025.128173
Minghan Li, Tianxu Pan, Juntong Yu, et al (2025) Butyrate-Producing Mixed Probiotics Alleviate MRSA-Induced Acute Lung Injury in Mice by Promoting M2 Macrophage Polarization. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-025-10520-7
Daniel McDonald, Gail L Ackermann, L. Khailová, et al (2016) Extreme Dysbiosis of the Microbiome in Critical Illness. Msphere. https://doi.org/10.1128/mSphere.00199-16
P. Jain, C. Mcnaught, A. D. Anderson, et al (2004) Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clinical Nutrition. https://doi.org/10.1016/J.CLNU.2003.12.002
L. Khailová, B. Petrie, C. Baird, et al (2014) Lactobacillus rhamnosus GG and Bifidobacterium longum Attenuate Lung Injury and Inflammatory Response in Experimental Sepsis. PLoS ONE. https://doi.org/10.1371/journal.pone.0097861
Boshra Bagdadi, Ali Alqazlane, May S. Alotaibi, et al (2024) The effectiveness of probiotics or synbiotics in the prevention and treatment of diarrhea among critically ill adults: a systematic review and meta-analysis. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2024.11.025
P. Wischmeyer, Daniel McDonald, R. Knight (2016) Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0000000000000321
V. Stadlbauer, R. Mookerjee, S. Hodges, et al (2008) Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2008.02.015
F. Di Pierro, S. Iqtadar, S. U. Mumtaz, et al (2022) Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study. Microorganisms. https://doi.org/10.3390/microorganisms10101926
N. Klingensmith, C. Coopersmith (2016) The Gut as the Motor of Multiple Organ Dysfunction in Critical Illness. Critical care clinics. https://doi.org/10.1016/j.ccc.2015.11.004
E. Litton, M. Anstey, David I. Broadhurst, et al (2021) Early and sustained Lactobacillus plantarum probiotic therapy in critical illness: the randomised, placebo-controlled, restoration of gut microflora in critical illness trial (ROCIT). Intensive Care Medicine. https://doi.org/10.1007/s00134-020-06322-w
J. Johnstone, D. Heels-Ansdell, L. Thabane, et al (2019) Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT. BMJ Open. https://doi.org/10.1136/bmjopen-2018-025228
A. Maraolo (2016) Reassessing the death risk related to probiotics in critically ill patients. Critical Care. https://doi.org/10.1186/s13054-016-1565-1
R. Koretz (2009) Probiotics, critical illness, and methodologic bias. Nutrition in clinical practice. https://doi.org/10.1177/0884533608329296
A. Boyer, M. Kollef (2013) Probiotics for ventilator-associated pneumonia: the need for a large, multicenter, randomized controlled trial. Chest. https://doi.org/10.1378/chest.12-2139
Orsalia Konsta, Vicky Linardatou, Yiannis Papachatzakis, et al (2026) Impact of Probiotic Administration and Nutrition on Gut Microbiota and Inflammation in Critically Ill Intensive Care Unit Patients: A Prospective Interventional Cohort Study. Health & Research Journal. https://doi.org/10.12681/healthresj.42827
F. Karacaer, I. Hamed, F. Özoğul, et al (2017) The function of probiotics on the treatment of ventilator‐associated pneumonia (VAP): facts and gaps. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.000579
Puput Fiohana (2025) THE EFFECT OF PROBIOTIC ADMINISTRATION ON THE GUT–LUNG AXIS IN REDUCING THE INCIDENCE OF PNEUMONIA: A SYSTEMATIC REVIEW. IJCNP (INDONESIAN JOURNAL OF CLINICAL NUTRITION PHYSICIAN). https://doi.org/10.54773/ijcnp.v7i1.263
C. Alberda, L. Gramlich, J. Meddings, et al (2007) Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition. https://doi.org/10.1093/AJCN/85.3.816
Jiaqi Lou, Shengyong Cui, Neng Huang, et al (2023) Efficacy of probiotics or synbiotics in critically ill patients: A systematic review and meta-analysis. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2023.11.003
Qianyi Yao, Tao Liu, Jingtao Wen, et al (2025) SpyTag-PEGylated probiotics delivering IL-1Ra modulate gut-lung crosstalk to mitigate septic lung injury. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.114163
Janaina Bach Naslowski, Maria Eliana Madalozzo Schieferdecker, Antônio Carlos Ligocki Campos (2025) "Effects of Probiotic Supplementation on Infectious and Gastrointestinal Complications of Critically Ill Patients: Randomized, Blinded, Placebo-Controlled Clinical Trial.". Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2025.05.006
L. Morrow (2009) Probiotics in the intensive care unit. Nutrition in clinical practice. https://doi.org/10.1097/MCC.0b013e3283252d2d
K. Julie, Özdener Ayse Elif (2018) The Role of Probiotics in Critically Ill Adult Patients with Pneumonia. International Journal of Critical Care and Emergency Medicine. https://doi.org/10.23937/2474-3674/1510049
F. Dawoodbhoy, B. Patel, K. Patel, et al (2020) Gut Microbiota Dysbiosis as a Target for Improved Post-Surgical Outcomes and Improved Patient Care. A Review of Current Literature. Shock. https://doi.org/10.1097/SHK.0000000000001654
S. Singhi, A. Baranwal (2008) Probiotic use in the critically ILL. Indian Journal of Pediatrics. https://doi.org/10.1007/s12098-008-0119-1
Nooshin Noshadi, M. Heidari, Mohammad Naemi Kermanshahi, et al (2022) Effects of Probiotics Supplementation on CRP, IL-6, and Length of ICU Stay in Traumatic Brain Injuries and Multiple Trauma Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2022/4674000
M. Falagas, I. Korbila, D. Karageorgopoulos (2010) Probiotics for the prevention of ventilator-associated pneumonia. Expert Review of Respiratory Medicine. https://doi.org/10.1586/ers.10.65
M. Kumari, B. Bhushan, Dolly Sharma, et al (2022) Gut Microbiome and COVID 19 Role of Probiotics on Gut Lung Axis. Defence Life Science Journal. https://doi.org/10.14429/dlsj.7.17786
Kentarou Shimizu, H. Ogura, T. Asahara, et al (2012) Probiotic/Synbiotic Therapy for Treating Critically Ill Patients from a Gut Microbiota Perspective. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-012-2334-x
Lindsay Urben, Jennifer Wiedmar, E. Boettcher, et al (2014) Bugs or Drugs: Are Probiotics Safe for Use in the Critically Ill? Current Gastroenterology Reports. https://doi.org/10.1007/s11894-014-0388-y
L. Morrow, V. Gogineni, M. Malesker (2012) Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Current opinion in clinical nutrition and metabolic care. https://doi.org/10.1097/MCO.0b013e32834fcea8
Zixuan Ren, Zhihuan Zheng, Xiujing Feng (2024) Role of gut microbes in acute lung injury/acute respiratory distress syndrome. Gut microbes. https://doi.org/10.1080/19490976.2024.2440125
T. Amrouche, M. Chikindas (2022) Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19. AIMS Microbiology. https://doi.org/10.3934/microbiol.2022024
Haley J. Chin, Zhiping Yu (2022) Impact of Prebiotics, Probiotics, and Synbiotics on Stool Output, Mortality, and Recovery in the Critically Ill. Topics in Clinical Nutrition. https://doi.org/10.1097/TIN.0000000000000299
L. Morrow (2009) Probiotics in the intensive care unit. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0b013e3283252d2d
Ruth Aritonang, Agustina Br Haloho (2026) CLINICAL APPLICATION OF PROBIOTICS IN INTENSIVE CARE UNIT (ICU). Indonesian Journal of Anesthesiology and Critical Care Medicine. https://doi.org/10.64531/ssz6ca94
M. Dehghani, F. Saghafi, Zeinab Bordbari, et al (2022) Investigating the effect of oral synbiotic on enteral feeding tolerance in critically ill patients: A double-blinded controlled clinical trial of gut microbiota. Nutrition in clinical practice. https://doi.org/10.1002/ncp.10895
Jia Dong James Wang, Enhui Suan, Sean Siwei Li, Vishal G Shelat (2025) Sepsis and the diverse organ-gastrointestinal tract axis. World Journal of Critical Care Medicine. https://doi.org/10.5492/wjccm.v14.i4.105547
Wan-Jie Gu, Jing-chen Liu (2013) Probiotics in critically ill patients: more data are needed. Chest. https://doi.org/10.1378/chest.12-2544
Bengt Klarin, M. Wullt, I. Palmquist, et al (2008) Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/j.1399-6576.2008.01748.x
Hadeer R. M. Tawfik, M. N. Farres, Rasha Samir, et al (2023) Effectiveness of Probiotics for Treatment of COVID-19: A Systematic Review and Meta-analysis. Trends Journal of Sciences Research. https://doi.org/10.31586/ujgh.2023.735
G. Stavrou, E. Giamarellos‐Bourboulis, K. Kotzampassi (2015) The role of probiotics in the prevention of severe infections following abdominal surgery. International Journal of Antimicrobial Agents. https://doi.org/10.1016/j.ijantimicag.2015.10.003
G. Mullin (2011) Comment On: Decrease in Frequency of Liquid Stool in Enterally Fed Critically Ill Patients Given the Multispecies Probiotic VSL#3: A Pilot Trial Frohmader TJ, Chaboyer WP, Robertson IK, Gowardman J. https://doi.org/10.1177/0884533610391811
Rajan P. Kulkarni (2019) Probiotics leap from gut to blood. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaz9763
E. O. Petrof, Rupinder Dhaliwal, William Manzanares (2013) Probiotika und Infektionsprävention bei kritisch Kranken. Krankenhaushygiene up2date. https://doi.org/10.1055/s-0033-1344426
Yanina Motta (2013) Utilización de probióticos en pacientes internados en un Hospitalespecializado enfermedades respiratorias
Sridesh Nath, Georgios D. Kitsios, L. Bos (2023) Gut–lung crosstalk during critical illness. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0000000000001015
C. Cruz, M. F. Ricci, A. T. Vieira (2021) Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.724033
Na Chen, Lianke Li, Yanhua Han, Zhu Chen (2025) The Role of Gut Microbiota in the Modulation of Pulmonary Immune Response to Viral Infection Through the Gut-Lung Axis. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S525880
G. L. V. de Oliveira, Camilla N. S. Oliveira, C. Pinzan, et al (2021) Microbiota Modulation of the Gut-Lung Axis in COVID-19. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.635471
A. C. Costanza, S. Moscavitch, H. C. F. Faria Neto, E. Mesquita (2015) Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2014.11.034
B. Haak, M. Levi, W. Wiersinga (2017) Microbiota-targeted therapies on the intensive care unit. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0000000000000389
Max C Jacobs, B. Haak, F. Hugenholtz, W. J. Wiersinga (2017) Gut microbiota and host defense in critical illness. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0000000000000424
Piyush Baindara, R. Chakraborty, Zachary M. Holliday, et al (2021) Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials. new microbes and new infections. https://doi.org/10.1016/j.nmni.2021.100837
P. D. B. Salzberger, C. Rauscher (2015) Das Mikrobiom des Darms beim kritisch kranken Patienten. Medizinische Klinik - Intensivmedizin und Notfallmedizin. https://doi.org/10.1007/s00063-015-0078-z
C. Zanza, Tatsiana Romenskaya, D. Thangathurai, et al (2021) Microbiome in Critical illness: An Unconventional and Unknown Ally. Current Medicinal Chemistry. https://doi.org/10.2174/0929867328666210915115056
Franco Rocco (2021) The Role Of Probiotics in the Symptomatic Treatment Of Covid-19. International Journal of Dentistry and Oral Science. https://doi.org/10.19070/2377-8075-21000477
K. Ho, Shankar Kalgudi, J. Corbett, E. Litton (2020) Gut microbiota in surgical and critically ill patients. Anaesthesia and Intensive Care. https://doi.org/10.1177/0310057X20903732
Nicole A Cho, Kathryn Strayer, Breenna Dobson, Braedon McDonald (2024) Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness. Gut microbes. https://doi.org/10.1080/19490976.2024.2351478
Yi-Hsiang Wang, Aniket Limaye, Je-Ruei Liu, Tai-Na Wu (2022) Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations. Journal of Traditional and Complementary Medicine. https://doi.org/10.1016/j.jtcme.2022.08.004
E. Scarpellini, L. Scarcella, G. Romanelli, et al (2021) Nutritional Status and the Critically Ill Patient: Gut Microbiota and Immuno-Nutrition in I.C.U. at the Time of SARS-COV 2 Pandemic. Gastroenterology Insights. https://doi.org/10.3390/GASTROENT12020022
S. Bengmark (2005) Synbiotics and the mucosal barrier in critically ill patients. Current Opinion in Gastroenterology. https://doi.org/10.1097/01.mog.0000182858.65927.81
Qiongling Sun, Jun Gao, Xuan Zhao, et al (2026) The gut-lung axis in severe pneumonia-related lung injury: mechanisms and therapeutic strategies. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1700534
Kevan M Akrami, D. Sweeney (2017) The microbiome of the critically ill patient. Current Opinion in Critical Care. https://doi.org/10.1097/MCC.0000000000000469
R. Nakov, J. Segal, C. Settanni, et al (2020) Microbiome: what intensivists should know. Minerva Anestesiologica. https://doi.org/10.23736/S0375-9393.20.14278-0
Qixiu Li, Xi-Cheng Song, Kefeng Li, Jing Wang (2025) Gut-lung immunometabolic crosstalk in sepsis: from microbiota to respiratory failure. Frontiers in Medicine. https://doi.org/10.3389/fmed.2025.1685044
Guosen Ou, Huachong Xu, Jialin Wu, et al (2023) The gut-lung axis in influenza A: the role of gut microbiota in immune balance. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1147724
S. Otani, Deena B. Chihade, C. Coopersmith (2018) Critical illness and the role of the microbiome. Acute Medicine & Surgery. https://doi.org/10.1002/ams2.383
S. Sanaie, M. Ebrahimi-Mameghani, A. Mahmoodpoor, et al (2013) Effect of a Probiotic Preparation (VSL#3) on CardiovascularRisk Parameters in Critically-Ill Patients. Journal of Cardiovascular and Thoracic Research. https://doi.org/10.5681/jcvtr.2013.014
Yuseok Moon, S. Pahari, Shikha Negi, E. Tsantikos (2025) Editorial: Mucosal microbiota immunomodulation of the gut-lung axis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1721724
F. Olímpio, J. D. da Silva, R. Vieira, et al (2022) Lacticaseibacillus rhamnosus modulates the inflammatory response and the subsequent lung damage in a murine model of acute lung inflammation. Clinics. https://doi.org/10.1016/j.clinsp.2022.100021
Zhengjian Wang, Jin Liu, Fan Li, et al (2022) The Gut-lung Axis in Severe Acute Panceatitis-associated Lung Injury: the Protection by the Gut Microbiota through Short-chain Fatty Acids. Pharmacological Research. https://doi.org/10.1016/j.phrs.2022.106321
Feng-Xian Ni, Hui-xian Wang, Jie Hu, et al (2026) The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1733726
M. Neag, A. Mitre, Irina Georgiana Pomana, et al (2025) Host–Microbiome Interaction in the Intensive Care Unit. Diseases. https://doi.org/10.3390/diseases13080250
Peter J. Watkinson, Vicki S Barber, P. Dark, J. D. Young (2007) The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. Clinical Nutrition. https://doi.org/10.1016/J.CLNU.2006.07.010
Chengkai Chen, Jiazi Lin, Xiao Wang, et al (2025) Novel insights into immune mechanisms in acute lung injury: Focusing on gut microbiota and its metabolites. Microbiology Research. https://doi.org/10.1016/j.micres.2025.128279
Kentarou Shimizu, H. Ogura, D. Kabata, et al (2018) Association of prophylactic synbiotics with reduction in diarrhea and pneumonia in mechanically ventilated critically ill patients: A propensity score analysis. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2018.06.006
A. Gerbitz, M. Schultz, Andrea Wilke, et al (2004) Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood. https://doi.org/10.1182/BLOOD-2003-11-3769
Inês Brandão, Tomoko Suzuki, Naser A. Alsharairi (2025) Editorial: Influence of dietary factors, nutrients, and the gut-lung axis on respiratory health. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2025.1556801
P. Konturek (2021) Wie wirkt sich COVID-19 auf die intestinale Mikrobiota aus? MMW - Fortschritte der Medizin. https://doi.org/10.1007/s15006-021-0200-5
Brett Macfarlane (2020) The lung microbiome and probiotics for respiratory infection
Monika Krezalek, Andrew Yeh, J. Alverdy, Michael J. Morowitz (2016) Influence of nutrition therapy on the intestinal microbiome. Current opinion in clinical nutrition and metabolic care. https://doi.org/10.1097/MCO.0000000000000348
Weiguo Song, Y. Yue, Qiang Zhang (2023) Imbalance of gut microbiota is involved in the development of chronic obstructive pulmonary disease: A review. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2023.115150
I. Cibulková, V. Řehořová, J. Hajer, F. Duška (2021) Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives. Biomolecules. https://doi.org/10.3390/biom11101459
N. Rayes, P. Soeters (2010) Probiotics in Surgical and Critically Ill Patients. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000309137
M. Mikelsaar (2011) Human microbial ecology: lactobacilli, probiotics, selective decontamination. Anaerobe. https://doi.org/10.1016/j.anaerobe.2011.07.005
Heather A. Vitko, Jordan J. Troxell, Paula R. Sherwood (2023) Probiotics for Infection Prevention in Critically Ill and Trauma Patients: A Concise Review. Journal of Trauma Nursing. https://doi.org/10.1097/JTN.0000000000000744
Ruoting Xu, Chuhong Tan, Jia Yin, Suyue Pan (2018) [Research progress of gut microbiota and microbiota-targeted therapy in critical ill patients]. Zhonghua wei zhong bing ji jiu yi xue. https://doi.org/10.3760/cma.j.issn.2095-4352.2018.011.018
S. Bengmark (2003) Use of some pre-, pro- and synbiotics in critically ill patients. Best practice & research Clinical gastroenterology. https://doi.org/10.1016/S1521-6918(03)00073-8
Heather A. Vitko, Jordan J. Troxell (2018) Probiotics in the critical care unit: fad, fact, or fiction? Journal of Emergency and Critical Care Medicine. https://doi.org/10.21037/JECCM.2018.11.02
M. Alves, Mireli de Santana Rêgo, Ruana Carolina Cabral da Silva, et al (2025) Gut Microbiota and COVID-19: Unraveling the Gut–Lung Axis and Immunomodulatory Therapies. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00250
A. Fabbrizzi, A. Amedei, F. Lavorini, et al (2019) The lung microbiome: clinical and therapeutic implications. Internal and Emergency Medicine. https://doi.org/10.1007/s11739-019-02208-y
Sandrayee Brahma, A. Naik, R. Lordan (2022) Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show? Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2022.08.023
F. Olímpio, J. Carvalho, V. Kaminsky, F. Aimbire (2022) Lacticaseibacillus rhamnosus attenuates acute lung inflammation in a murine model of acute respiratory distress syndrome: Relevance to cytokines associated to STAT4/T-bet and STAT3/RORɣt". Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2022.105831
Jie Gao, Huifang Chen, Liuyue Xu, et al (2023) Effects of Intestinal Microorganisms on Influenza-Infected Mice with Antibiotic-Induced Intestinal Dysbiosis, through the TLR7 Signaling Pathway. Frontiers in Bioscience. https://doi.org/10.31083/j.fbl2803043
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Bayu Anggara H (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
